期刊的影响因子--文章列表

期刊文章列表
Yi Yang^1,2，Makhloufi Zoulikha^1,2，Qingqing Xiao^2,3，Feifei Huang²，Qi Jiang²，Xiaotong Li²，Zhenfeng Wu⁴，Wei He^1,2（Shanghai Skin Disease Hospital，Tongji University School of Medicine；School of Pharmacy，China Pharmaceutical University；Department of Traditional Chinese Medicine Processing and Preparation，Nanjing University of Chinese Medicine；Key Laboratory of Modern Preparation of TCM，Ministry of Education，Jiangxi University of Chinese Medicine）.Pulmonary endothelium-targeted nanoassembly of indomethacin and superoxide dismutase relieves lung inflammation[J].Acta Pharmaceutica Sinica B,2023,第11期 Chang Xiao¹，Yue Sun^1,2，Jialong Fan¹，William Nguyen³，Simin Chen¹，Ying Long¹，Wei Chen³，Aiguo Zhu⁴，Bin Liu¹（College of Biology，Hunan University；General Hospital of Ningxia Medical University，School of Public Health and Management，Ningxia Medical University；Department of Physics，the University of Texas at Arlington；Institute of Bast Fiber Crops，Chinese Academy of Agricultural Sciences）.Engineering cannabidiol synergistic carbon monoxide nanocomplexes to enhance cancer therapy via excessive autophagy[J].Acta Pharmaceutica Sinica B,2023,第11期 Xiaoshuang Niu^1,2，Menghan Wu¹，Guodong Li¹，Xiuman Zhou²，Wenpeng Cao¹，Wenjie Zhai^1,3，Aijun Wu¹，Xiaowen Zhou¹，Shengzhe Jin¹，Guanyu Chen²，Yanying Li¹，Jiangfeng Du^1,3，Yahong Wu^1,3，Lu Qiu²，Wenshan Zhao^1,3，Yanfeng Gao²（School of Life Sciences，Zhengzhou University；School of Pharmaceutical Sciences (Shenzhen)，Shenzhen Campus of Sun Yat-sen University；International Joint Laboratory for Protein and Peptide Drugs of Henan Province，Zhengzhou University）.Identification and optimization of peptide inhibitors to block VISTA/PSGL-1 interaction for cancer immunotherapy[J].Acta Pharmaceutica Sinica B,2023,第11期 Ying Tao¹，Xinmiao Lan²，Yang Zhang³，Chenxing Fu⁴，Lu Liu⁵，Feng Cao³，Weisheng Guo¹（Department of Minimally Invasive Interventional Radiology，Key Laboratory of Molecular Target & Clinical Pharmacology，School of Biomedical Engineering & the Second Affiliated Hospital，Guangzhou Medical University；School of Pharmaceutical Sciences，Capital Medical University；Department of Cardiology，the Second Medical Center & National Clinical Research Center for Geriatric Diseases，Chinese PLA General Hospital；Department of Cardiology and Laboratory of Heart Center，Zhujiang Hospital，Southern Medical University；Department of Pharmacology and Pharmacy，Li Ka Shing Faculty of Medicine，the University of Hong Kong）.Biomimetic nanomedicines for precise atherosclerosis theranostics[J].Acta Pharmaceutica Sinica B,2023,第11期 Honggang Xiang，Mi Zhou，Yan Li，Lu Zhou，Renxiao Wang（Department of Medicinal Chemistry，School of Pharmacy，Fudan University）.Drug discovery by targeting the protein-protein interactions involved in autophagy[J].Acta Pharmaceutica Sinica B,2023,第11期 Yuegui Chen^1,2，Qin Yan^1,2，Yunheng Ji³，Xue Bai¹，Desen Li^1,2，Rongfang Mu^1,2，Kai Guo⁴，Minjie Yang¹，Yang Tao⁴，Jonathan Gershenzon⁵，Yan Liu^1,4，Shenghong Li^1,4（State Key Laboratory of Phytochemistry and Plant Resources in West China，Kunming Institute of Botany，Chinese Academy of Sciences；University of Chinese Academy of Sciences；Key Laboratory for Plant Diversity and Biogeography of East Asia，Kunming Institute of Botany，Chinese Academy of Sciences；State Key Laboratory of Southwestern Chinese Medicine Resources，Innovative Institute of Chinese Medicine and Pharmacy，Chengdu University of Traditional Chinese Medicine；Max Planck Institute for Chemical Ecology）.Unraveling the serial glycosylation in the biosynthesis of steroidal saponins in the medicinal plant Paris polyphylla and their antifungal action[J].Acta Pharmaceutica Sinica B,2023,第11期 Wanze Tang^1,2，Zhen Ding¹，Huanqing Gao¹，Qinnan Yan¹，Jingping Liu³，Yingying Han¹，Xiaoting Hou¹，Zhengwei Liu¹，Litong Chen¹，Dazhi Yang²，Guixing Ma¹，Huiling Cao¹（Department of Biochemistry，School of Medicine，Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research，Key University Laboratory of Metabolism and Health of Guangdong，Southern University of Science and Technology；The First Affiliated Hospital，Southern University of Science and Technology；Clinical Laboratory of the Third Affiliated Hospital of Southern Medical University）.Targeting Kindlin-2 in adipocytes increases bone mass through inhibiting FAS/PPARγ/FABP4 signaling in mice[J].Acta Pharmaceutica Sinica B,2023,第11期 Yuhan Li^1,2，Xiangqing Ding³，Xianxian Wu¹，Longfei Ding⁴，Yuhui Yang⁵，Xiaoliang Jiang¹，Xing Liu¹，Xu Zhang，Jianrong Su²，Jianqing Xu^3,7，Zhiwei Yang¹（Institute of Laboratory Animal Science，Chinese Academy of Medical Sciences (CAMS) & Comparative Medicine Centre，Peking Union Medical College (PUMC)；Department of Clinical Laboratory，Beijing Friendship Hospital，Capital Medical University；Shanghai Sinobay Biotechnology Company (Limited)；Shanghai Public Health Clinical Center，Fudan University；Capital Medical University；Department of Hepatobiliary Pancreatic Surgery，Zhengzhou University People’s Hospital，Henan Provincial People’s Hospital；Chongqing Institutes for Life Science Innovation）.A non-human primate derived anti-P-selectin glycoprotein ligand-1 antibody curtails acute pancreatitis by alleviating the inflammatory responses[J].Acta Pharmaceutica Sinica B,2023,第11期 Saifei Lei¹，Alice Guo²，Jie Lu¹，Qian Qi¹，Aaron S.Devanathan³，Junjie Zhu¹，Xiaochao Ma¹（Center for Pharmacogenetics，Department of Pharmaceutical Sciences，School of Pharmacy，University of Pittsburgh；School of Nursing，University of Pennsylvania；Department of Pharmacy and Therapeutics，School of Pharmacy，University of Pittsburgh）.Activation of PXR causes drug interactions with Paxlovid in transgenic mice[J].Acta Pharmaceutica Sinica B,2023,第11期 Xiaodong Zeng^1,2,3，Yuqin Liao^1,4,5，Xue Qiao^1,6，Ke Liang^1,2，Qiusi Luo^1,4,5，Mingbo Deng^1,4,5，Yishen Liu^1,4,5，Weijing Zhang^4,5,7，Xuechuan Hong^1,6,2，Yuling Xiao^1,4,5（State Key Laboratory of Virology，Department of Cardiology，Zhongnan Hospital of Wuhan University，School of Pharmaceutical Sciences，Wuhan University；Shenzhen Institute of Wuhan University；School of Biomedical Engineering，Shanghai Jiao Tong University；State Key Laboratory of Drug Research & Center of Pharmaceutics，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；Shandong Laboratory of Yantai Drug Discovery，Bohai Rim Advanced Research Institute for Drug Discovery；Key Laboratory of Biodiversity and Environment on the Qinghai-Tibetan Plateau，Ministry of Education，School of Ecology and Environment，Tibet University；School of Pharmacy，Yantai University）.Novel NIR-Ⅱ fluorescent probes for biliary atresia imaging[J].Acta Pharmaceutica Sinica B,2023,第11期 Kaican Zong，Hui Zhou，Wen Li，E Jiang，Yi Liu²，Shiying Li²（Department of Respiratory Medicine，the Seventh People’s Hospital of Chongqing (Affiliated Central Hospital of Chongqing University of Technology)；Department of Infectious Diseases，Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education)，Institute for Viral Hepatitis，the Second Affiliated Hospital，Chongqing Medical University）.Azvudine reduces the in-hospital mortality of COVID-19 patients：A retrospective cohort study[J].Acta Pharmaceutica Sinica B,2023,第11期 Yanyu Jiang，Shuaishuai Ni，Biying Xiao，Lijun Jia（Cancer Institute，Longhua Hospital，Shanghai University of Traditional Chinese Medicine）.Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy[J].Acta Pharmaceutica Sinica B,2023,第11期 Yuyi Xu，Ming Zhao，Jinxue Cao，Ting Fang，Jian Zhang，Yanli Zhen，Fangling Wu，Xiaohui Yu，Yaming Liu，Ji Li，Dongkai Wang（Department of Pharmaceutics，School of Pharmacy，Shenyang Pharmaceutical University）.Applications and recent advances in transdermal drug delivery systems for the treatment of rheumatoid arthritis[J].Acta Pharmaceutica Sinica B,2023,第11期 Peiliang Shen¹，Yuanyuan Jia¹，Weijia Zhou¹，Weiwei Zheng¹，Yueyao Wu¹，Suchen Qu¹，Shiyu Du¹，Siliang Wang^2,3，Huilian Shi⁴，Jia Sun¹，Xin Han¹（Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica，School of Medicine& Holistic Integrative Medicine，Jiangsu Joint International Research Laboratory of Chinese Medicine and Regenerative Medicine，Nanjing University of Chinese Medicine；Department of Pharmacy，Nanjing Drum Tower Hospital，The Affiliated Hospital of Nanjing University Medical School；Nanjing Medical Center for Clinical Pharmacy；Department of Infectious Diseases，Jiangsu Province Hospital of Chinese Medicine，Affiliated Hospital of Nanjing University of Chinese Medicine）.A biomimetic liver cancer on-a-chip reveals a critical role of LIPOCALIN-2 in promoting hepatocellular carcinoma progression[J].Acta Pharmaceutica Sinica B,2023,第11期 Rebecca R.Florke Gee^1,2，Andrew D.Huber¹，Jing Wu¹，Richa Bajpai，Allister J.Loughran，Shondra M.Pruett-Miller，Taosheng Chen¹（Department of Chemical Biology and Therapeutics，St.Jude Children's Research Hospital；Graduate School of Biomedical Sciences，St.Jude Children's Research Hospital；Department of Chemical Biology and Therapeutics，St.Jude Children’s Research Hospital；Center for Advanced Genome Engineering and Department of Cell and Molecular Biology，St.Jude Children’s Research Hospital）.The F-box-only protein 44 regulates pregnane X receptor protein level by ubiquitination and degradation[J].Acta Pharmaceutica Sinica B,2023,第11期 Qiuyue Liu^1,2，Jiahui Zou³，Zhongjian Chen¹，Wei He^1,3，Wei Wu^1,4,2,5（Shanghai Skin Disease Hospital，Tongji University School of Medicine；Key Laboratory of Smart Drug Delivery of MOE，School of Pharmacy，Fudan University；School of Pharmacy，China Pharmaceutical University；Shanghai Pudong Hospital，Fudan University Pudong Medical Center；Fudan Zhangjiang Institute）.Current research trends of nanomedicines[J].Acta Pharmaceutica Sinica B,2023,第11期 Xiaowei Wang^1,2，Mengyan Wang¹，Meilian Cai¹，Rongguang Shao¹，Guimin Xia²，Wuli Zhao¹（State Key Laboratory of Respiratory Health and Multimorbidity，Key Laboratory of Antibiotic Bioengineering，Ministry of Health，Laboratory of Oncology，Institute of Medicinal Biotechnology，Chinese Academy of Medical Sciences and Peking Union Medical College；Pharmaceutics Department，Institute of Medicinal Biotechnology，Chinese Academy of Medical Sciences and Peking Union Medical College）.Miriplatin-loaded liposome, as a novel mitophagy inducer, suppresses pancreatic cancer proliferation through blocking POLG and TFAM-mediated mtDNA replication[J].Acta Pharmaceutica Sinica B,2023,第11期 Zhongtang Li¹，Fan Fang¹，Yiyan Li¹，Xuehui Lv¹，Ruqiu Zheng¹，Peili Jiao¹，Yuxi Wang¹，Guiwang Zhu¹，Zefang Jin¹，Xiangqing Xu²，Yinli Qiu²，Guisen Zhang³，Zhongjun Li¹，Zhenming Liu¹，Liangren Zhang¹（State Key Laboratory of Natural and Biomimetic Drugs，School of Pharmaceutical Sciences，Peking University；Jiangsu Nhwa Pharmaceutical Co.，Ltd.；Jiangsu Key Laboratory of Marine Biological Resources and Environment，Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening，School of Pharmacy，Jiangsu Ocean University）.Carbazole and tetrahydro-carboline derivatives as dopamine D₃ receptor antagonists with the multiple antipsychotic-like properties[J].Acta Pharmaceutica Sinica B,2023,第11期 Jin Feng¹，Youle Zheng²，Mingyue Guo²，Irma Ares³，Marta Martínez³，Bernardo Lopez-Torres³，María-Rosa Martínez-Larra?aga³，Xu Wang^1,3，Arturo Anadón³，María-Aránzazu Martínezc¹（National Reference Laboratory of Veterinary Drug Residues(HZAU)and MAO Key Laboratory for Detection of Veterinary Drug Residues，Huazhong Agricultural University；MAO Laboratory for Risk Assessment of Quality and Safety of Livestock and Poultry Products，Huazhong Agricultural University；Department of Pharmacology and Toxicology，Faculty of Veterinary Medicine，Universidad Complutense de Madrid(UCM)，And Research Institute Hospital 12 de Octubre(i+12)）.Oxidative stress, the blood-brain barrier and neurodegenerative diseases：The critical beneficial role of dietary antioxidants[J].Acta Pharmaceutica Sinica B,2023,第10期 Defa Wu¹，Yang Li¹，Lang Zheng¹，Huan Xiao¹，Liang Ouyang¹，Guan Wang¹，Qiu Sun^1,2（Department of Biotherapy，Cancer Center and State Key Laboratory of Biotherapy，Innovation Center of Nursing Research，West China Hospital，Sichuan University/West China School of Nursing，Sichuan University；West China Medical Publishers，West China Hospital，Sichuan University）.Small molecules targeting protein-protein interactions for cancer therapy[J].Acta Pharmaceutica Sinica B,2023,第10期 Tianyuan Zhao^1,2，Xu Li³，Hao Li^1,2，Haoyuan Deng^1,2，Jianwei Li^1,2，Zhen Yang^1,2,4，Songlin He^1,2，Shuangpeng Jiang⁵，Xiang Sui¹，Quanyi Guo^1,2，Shuyun Liu^1,2（Institute of Orthopedics，The First Medical Center，Chinese PLA General Hospital，Beijing Key Lab of Regenerative Medicine in Orthopedics，Key Laboratory of Musculoskeletal Trauma&War Injuries PLA；School of Medicine，Nankai University；Musculoskeletal Research Laboratory，Department of Orthopedics&Traumatology，The Chinese University of Hong Kong；Arthritis Clinic&Research Center，Peking University People's Hospital，Peking University；Department of Joint Surgery，Beijing Shijitan Hospital，Capital Medical University）.Advancing drug delivery to articular cartilage：From single to multiple strategies[J].Acta Pharmaceutica Sinica B,2023,第10期 Wanting Zhang¹，Yuxin Jiang¹，Yonglong He¹，Hamza Boucetta¹，Jun Wu²，Zhongjian Chen³，Wei He^3,1（Department of Pharmaceutics，School of Pharmacy，China Pharmaceutical University；Department of Geriatric Cardiology，Jiangsu Provincial Key Laboratory of Geriatrics，The First Affiliated Hospital of Nanjing Medical University；Shanghai Skin Disease Hospital，Tongji University School of Medicine）.Lipid carriers for mRNA delivery[J].Acta Pharmaceutica Sinica B,2023,第10期 Shugang Qin，Hai Huang，Wen Xiao，Kepan Chen，Xi He，Xiaoshan Tang，Zhiying Huang，Yupei Zhang，Xing Duan，Na Fan，Qian Zheng，Min Wu，Guangwen Lu，Yuquan Wei，Xiawei Wei，Xiangrong Song（Department of Critical Care Medicine，Frontiers Science Center for Disease-related Molecular Network，State Key Laboratory of Biotherapy and Cancer Center，West China Hospital，Sichuan University）.A novel heterologous receptor-binding domain dodecamer universal mRNA vaccine against SARS-CoV-2 variants[J].Acta Pharmaceutica Sinica B,2023,第10期 Yu Zhang¹，Ruizhe Huang¹，Yunchun Jiang¹，Wenhao Shen¹，Hailong Pei¹，Guanglin Wang¹，Pei Pei²，Kai Yang¹（State Key Laboratory of Radiation Medicine and Protection，School of Radiation Medicine and Protection&School for Radiological and Interdisciplinary Sciences(RAD-X)，Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions，Soochow University；Teaching and Research Section of Nuclear Medicine，School of Basic Medical Sciences，Anhui Medical University）.The role of bacteria and its derived biomaterials in cancer radiotherapy[J].Acta Pharmaceutica Sinica B,2023,第10期 Yixin Chen^1,2，Mei-Juan Tu¹，Fangwei Han³，Zhenzhen Liu¹，Neelu Batra¹，Primo N.Lara⁴，Hong-Wu Chen¹，Huichang Bi²，Ai-Ming Yu¹（Department of Biochemistry and Molecular Medicine，School of Medicine，UC Davis；School of Pharmaceutical Sciences，Sun Yat-sen University；School of Public Health，UNT Health Science Center；Department of Internal Medicine，School of Medicine，UC Davis）.Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancer[J].Acta Pharmaceutica Sinica B,2023,第10期 Dejuan Sun¹，Yuanyuan Guo¹，Piyu Tang¹，Hua Li^1,2，Lixia Chen¹（Wuya College of Innovation，Key Laboratory of Structure-Based Drug Design&Discovery，Ministry of Education，Shenyang Pharmaceutical University；College of Pharmacy，Fujian University of Traditional Chinese Medicine）.Arf6 as a therapeutic target：Structure,mechanism, and inhibitors[J].Acta Pharmaceutica Sinica B,2023,第10期首页上一页 1 2 3 4 5 下一页尾页共有11页，转到页

期刊文章列表